- Injective (INJ) price forecast as Republic enhances RWA integration with Injective.
- The INJ token is trading at approximately $13.38 after a drop from highs of $16 during the crypto market downturn.
- Expectations around ETFs, growth in tokenization, and other factors may bolster INJ bulls.
As of Thursday evening, Injective’s price stands around $13.38, reflecting a 3% decline over the past 24 hours and more than 12% in the past week. Will Injective’s partnership with Republic propel the price back to $20?
In the past week, Injective has fallen from peaks of $16, compounded by widespread market sell-off pressure.
This occurs despite the finance-focused layer 1 blockchain’s impressive achievements within the ecosystem.
With Republic, a leading platform for tokenized investments, bulls could aim for higher targets if market conditions turn favorable.
Injective partners with Republic
As the crypto landscape faces challenges, platforms are taking the opportunity to innovate.
Integrations are vital, and Injective has strengthened its position with its formal partnership with Republic.
The platforms announced this collaboration on August 21 and plan to integrate Injective’s Layer 1 ecosystem into Republic’s on-chain investment framework.
The specific aim is to enable Injective-based projects to raise funds through Republic’s Launchpad, use Republic Wallet for managing assets, and gain assistance from Republic’s validators.
What makes this integration significant?
Republic and Injective are building upon a previous partnership that established Republic as an INJ validator.
Importantly, this integration marks a step forward in expanding private markets on-chain.
“With over 3 million community members across more than 150 countries and a portfolio including 27 unicorns such as SpaceX, Robinhood, Carta, and Dapper Labs, Republic’s integration with Injective represents a critical moment in linking traditional finance to on-chain advancements,” Injective stated.
INJ price forecast: Can bulls regain $30?
The technical outlook for INJ appears bearish in the short term, with both RSI and MACD favoring bears.
Currently priced around $13, Injective is closer to the lows of $6.90 experienced in April 2025 than the recent high of $34 reached in December 2024.
The downturn affecting Bitcoin and altcoins is not beneficial for bulls.
However, if market sentiment improves, a breakout to $20 could inspire bulls to set their sights on the $30 mark.
In addition to the Republic initiative, significant upward drivers will include overall institutional interest and demand amid tokenization and real-world asset developments.
Injective’s ambition to lead with innovative financial tools designed to enhance its DeFi capabilities, along with the growth of the Nvidia GPU derivatives market, adds to the positive outlook.
Also favorable for Injective’s price are expectations surrounding ETF filings and approvals, with whale accumulation playing a critical role.
Bulls, however, must maintain prices above $13 and ideally above $10 to avoid ceding more ground to bears.
